AVNT vs KWR vs CBT vs FUL

For growth investors, Quaker Chemical Corporation (KWR) is the stronger pick with 2.

7% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). Cabot Corporation (CBT) offers the better valuation at 13. 5x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Avient Corporation (AVNT) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Cabot Corporation (CBT) is the cheapest at 13.

5x versus Avient Corporation at 41. 0x. On forward P/E, Avient Corporation is actually cheaper at 12. 0x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Cabot Corporation (CBT) delivered a total return of +43.

2%, compared to -37. 3% for Quaker Chemical Corporation (KWR). Over 10 years, the gap is even starker: CBT returned +115. 7% versus AVNT's +27. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cabot Corporation (CBT) is the lower-risk stock at 0.

78β versus Quaker Chemical Corporation's 1. 35β — meaning KWR is approximately 72% more volatile than CBT relative to the S&P 500. On balance sheet safety, Quaker Chemical Corporation (KWR) carries a lower debt/equity ratio of 67% versus 101% for H. B. Fuller Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Quaker Chemical Corporation (KWR) is pulling ahead at 2.

7% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: H. B. Fuller Company grew EPS 19. 6% year-over-year, compared to -102. 2% for Quaker Chemical Corporation. Over a 3-year CAGR, KWR leads at -1. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Cabot Corporation (CBT) is the more profitable company, earning 8.

9% net margin versus -0. 1% for Quaker Chemical Corporation — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBT leads at 16. 7% versus 6. 2% for AVNT. At the gross margin level — before operating expenses — KWR leads at 36. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Avient Corporation (AVNT) trades at 12.

0x forward P/E versus 19. 3x for Quaker Chemical Corporation — 7. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVNT: 32. 6% to $48. 40.

All stocks in this comparison pay dividends.

Avient Corporation (AVNT) offers the highest yield at 2. 9%, versus 1. 4% for Quaker Chemical Corporation (KWR).

For long-horizon retirement investors, Cabot Corporation (CBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

78), 2. 2% yield, +115. 7% 10Y return). Both have compounded well over 10 years (CBT: +115. 7%, KWR: +88. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AVNT is a small-cap quality compounder stock; KWR is a small-cap quality compounder stock; CBT is a small-cap deep-value stock; FUL is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.